U.S. CDC finds more clotting cases after J&J vaccine, sees causal link
It said the events appear similar to what is being observed following administration of the AstraZeneca COVID-19 vaccine in Europe.
Written By:
Michael Erman and Julie Steenhuysen / Reuters | 11:13 am, May 12, 2021 ×
Dado Ruvic / REUTERS
CHICAGO, May 12 (Reuters) - The U.S. Centers for Disease Control and Prevention said on Wednesday it had found more cases of potentially life-threatening blood clotting among people who received the Johnson & Johnson COVID-19 vaccine and sees a plausible causal association.
The CDC said in a presentation the agency has now identified 28 cases of thrombosis with thrombocytopenia syndrome (TTS) among the more than 8.7 million people who had received the J&J vaccine. TTS involves blood clots accompanied by a low level of platelets - the cells in the blood that help it to clot.
Share this article
Share this article
OMAHA, Neb., May 10, 2021 /PRNewswire/ Vishal M. Kothari, MD, FACS, is being recognized by Continental Who s Who as a Top Surgeon for his outstanding contributions to the fields of Medicine & Education and acknowledgment of his professional excellence with Nebraska Medicine – Lauritzen Outpatient Center.
Vishal M. Kothari, MD, FACS
Board Certified General Surgeon Dr. Kothari, is currently serving patients within the Nebraska Medicine healthcare network. He practices at Nebraska Medicine – Lauritzen Outpatient Center in Omaha, Nebraska, and also sees patients within the Bariatrics Center at the Nebraska Medical Center, as well as the Multispecialty Clinic at Village Pointe Health Center. At these offices, the highly trained medical professionals are dedicated to providing quality, expert services for a wide range of issues including acid reflux, gallstones, appendicitis, hernias, intestinal surgery, minima
Allegheny Health Network Specialists Explore Use of Novel Eye Tracking Technology to Assess Long Lasting COVID related Neurological Problems
Share Article
Doctors at Allegheny Health Network (AHN), led by neurologist Kevin M. Kelly, MD, PhD, are studying use of a novel technology to assess the long term neurological effects of the COVID-19 virus on some patients.
“For months, many of these patients have been advised to ‘just deal with it,’ and that’s not an effective approach,” said Dr. Kelly. PITTSBURGH (PRWEB) May 10, 2021 Doctors at Allegheny Health Network (AHN), led by neurologist Kevin M. Kelly, MD, PhD, are studying use of a novel technology to assess the long term neurological effects of the COVID-19 virus on some patients. The research, funded by Neurolign Technologies, is exploring the efficacy of Neurolign’s computerized eye movement tracking goggles for helping to analyze a patient’s oc